Showing 7,617 news articles about Health services & systems

Filters Content type: Editors' picks Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

Pharmaceutical industry

Gilead targets 'large-scale' HIV drugs counterfeiting scheme as judge orders asset freeze

Editor's pick
FiercePharma
30 September 2022
Access to healthcare

How a Danish Company Grabbed Control of the Monkeypox Vaccine

Editor's pick
The American Prospect
30 September 2022
Mpox

‘It is sinking us even further’: US STI clinics, already stretched thin, strain under weight of monkeypox response

Editor's pick
STAT
30 September 2022
Global health initiatives

Reimagining PEPFAR at 20 to End the HIV/AIDS Pandemic by 2030

Editor's pick
US Department of State
26 September 2022
HIV testing programmes & uptake

Programs Designed to Promote HIV Testing May Worsen Misinformation, Stigma

Editor's pick
Infectious Disease Advisor
26 September 2022
People who inject drugs

HIV spike among B.C. drug users associated with COVID-19-related service closures, research says

Editor's pick
CBC
26 September 2022
HIV prevention policy

To Meet Global HIV Prevention Goals, Expand The PEPFAR-FDA Tentative Approval Pathway

Editor's pick
Health Affairs
25 September 2022
Sexual health

What do healthcare workers really think of mHealth?

Editor's pick
Be In The Know
23 September 2022
Mpox

England's Health Secretary must prioritise monkeypox's devastating impact on sexual health services

Editor's pick
Terrence Higgins Trust
22 September 2022
Finance & funding

Global Fund Partners Pledge Record Level of Support to End Deadly Diseases, Prevent Future Pandemics

Editor's pick
The Global Fund
22 September 2022
Finance & funding

Global Fund Still Short of $18 Billion Target – But UK and Italy Have Yet to Announce Pledges

Editor's pick
Health Policy Watch
22 September 2022
Global health initiatives

Global Fund gets powerful help with $18 billion funding goal

Editor's pick
Associated Press
20 September 2022
New & experimental HIV treatments

Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 Infection

Editor's pick
Merck press release
20 September 2022
Mpox

TPoxx antiviral should only be given to high-risk monkeypox patients, CDC says

Editor's pick
The Washington Post
16 September 2022
The search for an HIV prevention vaccine

HIV Vaccine Still Years Away, Former AIDS Society Head Warns

Editor's pick
Bloomberg
15 September 2022
Epidemiology

HIV infections rose in San Francisco for first time in a decade, perhaps due to pandemic

Editor's pick
San Francisco Chronicle
14 September 2022
Pharmaceutical industry

Gilead settles patent fight with generic drugmakers over HIV drugs

Editor's pick
Reuters
13 September 2022
Mpox

Monkeypox Shots, Treatments and Tests Are Unavailable in Much of the World

Editor's pick
The New York Times
12 September 2022
Access to healthcare

Counterfeit HIV Meds Are Endangering Some of America’s Most Vulnerable People

Editor's pick
VICE
12 September 2022
Finance & funding

UNAIDS commends Germany’s pledge of €1.3 billion for the 7th Global Fund Replenishment

Editor's pick
UNAIDS
8 September 2022
PrEP policies & guidelines

AVAC Condemns Court Decision that Tramples Human Rights, Reinforces Homophobia and Denies Life-Saving PrEP Drugs to Individuals in Texas

Editor's pick
AVAC
8 September 2022
PrEP policies & guidelines

Denial of Coverage for PrEP is Dangerous and Unacceptable

Editor's pick
HIV Medicine Association
8 September 2022
Combatting stigma

UNAIDS launches new platform on ending HIV-related stigma and discrimination in the Asia and Pacific region

Editor's pick
UNAIDS
7 September 2022
Global health initiatives

Countries must re-engage on HIV, TB and malaria

Editor's pick
Médecins Sans Frontières
7 September 2022